Staphylokinase reduces plasmin formation by endogenous plasminogen activators

European Journal of Haematology

Volumn 81, Issue 1, 2008, Pages 8-17

  Jin, Tao ^a,b   Bokarewa, Maria ^a   Zhu, Yihong ^a   Tarkowski, Andrej ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Hyperfibrinolysis; Plasminogen; Staphylokinase; Tissue type plasminogen activator; Urinary plasminogen activator

Indexed keywords

AMMONIA; PLASMIN; PLASMINOGEN ACTIVATOR; STAPHYLOKINASE; UROKINASE;

ADULT; ARTICLE; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; FIBRINOLYSIS; HUMAN; MALE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION;

ADULT; FEMALE; FIBRINOLYSIS; HUMANS; MALE; METALLOENDOPEPTIDASES; MIDDLE AGED; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATORS; RECOMBINANT PROTEINS; TISSUE PLASMINOGEN ACTIVATOR; URINARY PLASMINOGEN ACTIVATOR;

EID: 45449111187     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01066.x     Document Type: Article

References (22)

1. Jin T, Bokarewa M, McIntyre L, Tarkowski A, Corey GR, Reller LB, Fowler VG Jr. Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains. J Med Microbiol 2003 52 : 919 23.
2. Collen D, Schlott B, Engelborghs Y, Van Hoef B, Hartmann M, Lijnen HR, Behnke D. On the mechanism of the activation of human plasminogen by recombinant staphylokinase. J Biol Chem 1993 268 : 8284 9.
3. Collen D. Staphylokinase: a potent, uniquely fibrin- selective thrombolytic agent. Nat Med 1998 4 : 279 84.
4. Collen D, Lijnen HR. Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991 78 : 3114 24.
5. Robbins KC, Summaria L, Hsieh B, Shah RJ. The peptide chains of human plasmin. Mechanism of activation of human plasminogen to plasmin. J Biol Chem 1967 242 : 2333 42.
6. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991 88 : 1067 72.
7. Violl F, Basili S, Ferro D, Quintarelli C, Alessandril C, Cordova C. Association between high values of D-dimer and tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients. CALC Group. Thromb Haemost 1996 76 : 177 83.
8. Porte RJ, Bontempo FA, Knot EA, Lewis JH, Kang YG, Starzl TE. Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation 1989 47 : 978 84.
9. Stibbe J, Kluft C, Brommer EJ, Gomes M, de Jong DS, Nauta J. Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator. Eur J Clin Invest 1984 14 : 375 82.
10. Levi M, de Jonge E, van der Poll T, ten Cate H. Disseminated intravascular coagulation. Thromb Haemost 1999 82 : 695 705.
11. Collen D, Lijnen HR. Thrombolytic agents. Thromb Haemost 2005 93 : 627 30.
12. Laroche Y, Heymans S, Capaert S, De Cock F, Demarsin E, Collen D. Recombinant staphylokinase variants with reduced antigenicity due to elimination of B-lymphocyte epitopes. Blood. 2000 96 : 1425 32.
13. Gase A, Hartmann M, Guhrs KH, Rocker A, Collen D, Behnke D, Schlott B. Functional significance of NH2- and COOH-terminal regions of staphylokinase in plasminogen activation. Thromb Haemost 1996 76 : 755 60.
14. Gase A, Birch-Hirschfeld E, Guhrs KH, Hartmann M, Vetterman S, Damaschun G, Damaschun H, Gast K, Misselwitz R, Zirwer D. The thermostability of natural variants of bacterial plasminogen-activator staphylokinase. Eur J Biochem 1994 223 : 303 8.
15. Jones AJ, Meunier AM. A precise and rapid microtitre plate clot lysis assay: methodology, kinetic modeling and measurement of catalytic constants for plasminogen activation during fibrinolysis. Thromb Haemost 1990 64 : 455 63.
16. Jin T, Bokarewa M, Foster T, Mitchell J, Higgins J, Tarkowski A. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism. J Immunol 2004 172 : 1169 76.
17. Silence K, Hartmann M, Guhrs KH, Gase A, Schlott B, Collen D, Lijnen HR. Structure-function relationships in staphylokinase as revealed by "clustered charge to alanine" mutagenesis. J Biol Chem 1995 270 : 27192 8.
18. Bokarewa M, Tarkowski A. Human alpha -defensins neutralize fibrinolytic activity exerted by staphylokinase. Thromb Haemost 2004 91 : 991 9.
19. Higazi AA, Barghouti II, Abu-Much R. Identification of an inhibitor of tissue-type plasminogen activator-mediated fibrinolysis in human neutrophils. A role for defensin. J Biol Chem 1995 270 : 9472 7.
20. Bajaj AP, Castellino FJ. Activation of human plasminogen by equimolar levels of streptokinase. J Biol Chem 1977 252 : 492 8.
21. Parry MA, Fernandez-Catalan C, Bergner A, Huber R, Hopfner KP, Schlott B, Guhrs KH, Bode W. The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase- cofactor-substrate complex in action. Nat Struct Biol 1998 5 : 917 23.
22. Jin T, Bokarewa M, Tarkowski A. Urokinase-type plasminogen activator, an endogenous antibiotic. J Infect Dis 2005 192 : 429 37.